“Help the Filipino skin patients and consumers live, enjoy and pursue their lives to the fullest by providing quality and affordable solutions to their acute and chronic skin and aesthetic problems.”
It all began when GSK signified its interest in buying Stiefel after the latter floated its desire to sell the business. The intent and spirit to form a homegrown dermatology company among the movers were strong and resolute. The search for interested investors began as soon as the imminent takeover became apparently clear in mid 2009. Even before integration work between the merged companies started in October, the blueprint for the creation of Eskeen has been laid out in Bohol in July 2009. And the rest they say is history. A young history of struggles and successes. From that moment on, Eskeen has been led by an executive team of experience-wealthy, customer-engaged and sleeves-rolled up individuals who are focused on key functions like marketing, finance, sales, R&D and supply chain.
The intent to establish a national company was borne out of talks about the impending acquisition of Stiefel by GSK.
The 5 people now comprising the Leadership Team decided not to join the integrated Stiefel-GSK team.
Talks with investors began.
Eskeen was incorporated.
Organization work and manufacturing facilities sourcing commenced.
Commercial operations started with the LT doing admin, regulatory and commercial works by themselves along with 3 medical representatives.
This period was characterized by consistent growth in portfolio and revenue that makes Eskeen currently the biggest homegrown, privately-owned dermatology specialty company in the Philippines.